MNKD-201, an inhaled formulation of nintedanib for IPF, was shown to be safe and well tolerated in a clinical trial with ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

Ludhiana grapples with thick smog as pollution levels rise, leading to an alarming increase in respiratory distress cases ...

A chemist in east Delhi says that there was a significant rise in demand for pediatric nebulisers and low-dose inhalers this ...

Thirteen-year-old Maira said the smog is overwhelming on her way to school. “It’s really sad to see Delhi like this. It was supposed to be green, but now it’s grey,” said the teenager who accompanied ...

Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

AptarGroup held a groundbreaking ceremony for a new pharmaceutical plant in Taloja, India. The facility expands AptarGroup's ...

Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

The Nasal Drug Delivery Technology Market is driven by the rising demand for non-invasive administration methods that enhance patient compliance and bioavailability. Innovations such as advanced ...

Lupin Healthcare UK Ltd has announced plans to reformulate its pMDI inhalers with a near-zero global warming potential ...

Why do lots of people get chest infections during the winter?